Adequan for Dogs: Uses, Cost & How It Helps Joints

This guide is educational and should not replace care from your vet. Adequan Canine is a prescription injectable medication, and the right plan depends on your dog's diagnosis, weight, bleeding risk, other medications, and overall health.

See your vet immediately if your dog has severe pain, cannot rise, has sudden non-weight-bearing lameness, unusual bruising, nosebleeds, blood in vomit, black stool, or marked swelling after an injection. Those signs are not typical day-to-day arthritis changes and need prompt medical attention.

If your dog already takes NSAIDs, steroids, anticoagulants, or supplements marketed for joints, tell your vet before starting Adequan. Combination plans are common, but they should be chosen thoughtfully and monitored over time.

Adequan Canine is an injectable prescription medication containing polysulfated glycosaminoglycan, often shortened to PSGAG. It is FDA-approved for intramuscular use in dogs with non-infectious degenerative or traumatic arthritis. Unlike medications that mainly target pain, Adequan is used to support joint tissues and help slow some of the cartilage damage linked with osteoarthritis.

PSGAG is considered a disease-modifying osteoarthritis drug, or DMOAD. Research and manufacturer data suggest it reaches synovial joints quickly after injection and may reduce cartilage-degrading enzymes, support joint fluid quality, and encourage production of cartilage-related building blocks. In practical terms, that means some dogs move more comfortably, rise more easily, and show less stiffness after the loading series.

It is not a cure, and it does not reverse advanced arthritis. Still, it can be a useful option early in the disease process or as one part of a broader arthritis plan that may also include weight management, home exercise changes, rehabilitation, and pain control.

Your vet may recommend Adequan for dogs with osteoarthritis caused by age-related wear, prior orthopedic injury, cruciate disease, hip dysplasia, elbow dysplasia, or other joint instability. It is labeled for non-infectious degenerative and traumatic arthritis, so it is not the right choice for every painful joint problem.

Many dogs do best when Adequan is started before joint damage becomes severe. That does not mean older dogs cannot benefit. It means the medication tends to fit best when there is still meaningful joint function to preserve. Pet parents often notice goals like easier standing, less stiffness after rest, smoother walks, or better willingness to use stairs.

Adequan is commonly used alongside other options rather than by itself. Depending on your dog's needs, your vet may pair it with an NSAID, weight-loss support, rehab exercises, traction at home, omega-3s, or newer arthritis therapies. The best plan is the one that matches your dog's comfort, medical history, and your family's budget and routine.

The FDA-approved Adequan Canine dose is 2 mg/lb (4.4 mg/kg) by intramuscular injection only. The labeled schedule is twice weekly for up to 4 weeks, for a maximum of 8 injections in the initial loading series.

A practical dosing shortcut often used in clinics is 1 mL per 50 lb body weight, because the product concentration is 100 mg/mL. Your vet will calculate the exact volume for your dog and decide whether the injections should be given in the clinic or, in some cases, taught for home administration.

After the loading series, some dogs stop and are reassessed, while others continue on a maintenance plan. Maintenance schedules vary and are often extra-label, such as every 2 to 6 weeks depending on response. That is one reason follow-up matters. If your dog improves, your vet can help you decide whether to continue, taper, or combine Adequan with other arthritis care.

Adequan is generally well tolerated. Reported reactions in clinical studies were uncommon, with adverse reactions noted after about 2.1% of injections. The most common issues are mild and short-lived, including soreness at the injection site, diarrhea, vomiting, or reduced appetite.

The more important safety concern is bleeding risk. PSGAG has effects related to clotting, so dogs with known or suspected bleeding disorders need careful screening before use. Contact your vet promptly if you notice unusual bruising, nosebleeds, prolonged bleeding, swelling or a hematoma at the injection site, black stool, or blood in urine or vomit.

Tell your vet if your dog has liver disease, kidney disease, a history of low platelets, or is scheduled for surgery or dental work. Those details can change whether Adequan is a good fit now, later, or only with extra monitoring.

The biggest interaction concern is with medications or conditions that affect clotting. That includes anticoagulants, antiplatelet drugs, some supplements, and dogs with inherited or acquired bleeding disorders. If your dog has ever had unexplained bruising or prolonged bleeding, mention that before the first injection.

Adequan is often used in a multimodal arthritis plan, and many dogs receive it alongside NSAIDs under veterinary supervision. That combination can be appropriate, but it still deserves monitoring because arthritis patients are often older and may have other health issues at the same time.

Steroids, upcoming surgery, dental procedures, and other injectable medications are also worth discussing with your vet. Bring a full medication and supplement list to the appointment, including fish oil, aspirin products, and anything bought over the counter.